Analysis of parameters affecting autologous arteriovenous fistula functional maturation in a population of patients with end-stage renal disease
10.3760/cma.j.issn.1672-7088.2017.14.006
- VernacularTitle:影响终末期肾脏病患者自体动静脉内瘘成熟因素分析
- Author:
Aiying HU
;
Xueping YIN
;
Ping LI
;
Yan ZHOU
;
Ping LU
- Keywords:
Renal dialysis;
End-stage renal disease;
Arteriovenous fistula;
Maturation
- From:
Chinese Journal of Practical Nursing
2017;33(14):1063-1066
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate demographic factors implicated in the functional maturation of autologous arteriovenous fistula in a population of patients with end-stage renal disease. Methods The data of 335 consecutive patients with end-stage renal disease who were performed autologous arteriovenous fistula from January 2010 to December 2015 were analyzed retrospectively. The parameters affecting autologous arteriovenous fistula functional maturation were screened. Results Overall arteriovenous fistula functional maturation rate was 78.14%(218/279). The arteriovenous fistula functional maturation rate was 68.33%(82/120) in diabetes and 85.54%(136/159) in non-diabetes, and there was significant difference (χ2=11.844, P<0.01). The arteriovenous fistula functional maturation rate was 62.26%(33/53) in hypoproteinemia and 81.86%(185/226) in non-hypoproteinemia, and there was significant difference (χ2=9.648, P<0.01). Diabetes and hypoproteinemia were the risk factors to promote functional maturation (OR=6.003, 8.476). The arteriovenous fistula functional maturation rate was 87.10%(81/93) in calcium channel blockers using and 73.66%(137/186) in non-calcium channel blockers using, and there was significant difference (χ2=6.556, P<0.05). Calcium channel blockers was the protective factor for promoting functional maturation (OR=0.086). Conclusions Diabetes and hypoproteinemia are found to be associated with functional non-maturation, while calcium channel-blocker agents are associated with better functional maturation.
